AstraZeneca has reinforced its commitment to advancing cancer care through early detection, innovative treatments, and equitable healthcare access in recognition of World Cancer Day 2025 under the ...
The firm scrapped its £450m investment despite the government's offer of support, the government says.
AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...
15h
If you purchased or acquired securities in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like ...
PHARMACEUTICAL giant AstraZeneca has scrapped plans for a £450m (US$559m) upgrade to its vaccine manufacturing facility in ...
LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
AstraZeneca PLC closed 15.78% below its 52-week high of £133.88, which the company achieved on September 3rd.
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
Daily Independent on MSN3h
AstraZeneca reaffirms commitment to cancer care on World Cancer Day 2025 with innovative solutionsJOHANNESBURG: In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback